125 results
Page 5 of 7
424B5
vw2ydd10suklnxh50
17 Oct 19
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
1kbulw3gb
17 Oct 19
Natera Launches Proposed Follow-On Offering
5:29pm
S-3ASR
ga5s24j zlwhzjt
15 Oct 19
Automatic shelf registration
5:24pm
8-K
EX-99.1
6w9l to1fnjm
10 Oct 19
Regulation FD Disclosure
4:16pm
8-K
k8i2v bo0
24 Sep 19
Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring
7:21am
8-K
EX-99.1
jrds s33r8k0
24 Sep 19
Foundation Medicine and Natera Partner to Advance Personalized Cancer Monitoring
7:21am
424B5
ix0gxdy9n7tyb59x
29 Apr 19
Prospectus supplement for primary offering
4:20pm
8-K
EX-1.1
jeylg227hidngaj7 4ky
18 Apr 19
Natera Launches Proposed Follow-On Offering
5:12pm
424B5
kcqs368s
18 Apr 19
Prospectus supplement for primary offering
5:04pm
S-3ASR
fsu7f4v9ckpo9zlhh
16 Apr 19
Automatic shelf registration
4:05pm
8-K
EX-99.2
bzq546
12 Mar 19
Natera Reports Fourth Quarter and Fiscal Year 2018 Financial Results
4:16pm
8-K
dem7c55suglrhgu8
8 Jan 19
Departure of Directors or Certain Officers
4:07pm